Sun Pharma Signs Global Licensing Deal With LIB Therapeutics For Lerodalcibep, Lyrokaul Approved In EU Targets USD 3.7 Billion Market

Sun Pharma has made a big global deal. On 28th September 2026, Sun Pharma and a US company called LIB Therapeutics said they have signed an ...

Read More →